Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2005
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2093306C (1-h-indol-1-yl)-2-(amino)acetamides and related (1h-indol-1-yl)-(aminoalkyl)amides, intermediates and a process for their preparation and their use as medicaments
09/22/2005WO2005087761A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087731A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087730A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087729A1 5-hydroxyindole-3-carboxylates derivatives and their use
09/22/2005WO2005087728A1 Resistance-repellent retroviral protease inhibitors
09/22/2005WO2005087727A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087726A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
09/22/2005WO2005087721A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005086735A2 Novel bicyclic compounds as modulators of androgen receptor function and method
09/22/2005US20050209486 (1R, 2S)-2-amino-1-(4-hydroxyphenyl)propan-1-ol) ; used to make agents for prevention or treatment of obesity, hyperglycemia or a disease caused by intestinal tract hypermotility
09/22/2005US20050209465 By reacting with substituted acetylenes in the presence of a phosphine ligand and a base (K2CO3); used to make drugs
09/22/2005US20050209464 Dyeing composition; oxidation-dyeing keratin fibers
09/22/2005US20050209333 Malonamic acids and derivatives thereof as thyroid receptor ligands
09/22/2005US20050209307 Cardiovascular disorders; antiarrhythmia agents as result od analgesics, anesthetics
09/22/2005US20050209302 Glycogen synthase kinase (GSK-3) inhibitors; diabetes, neurodegenerative diseases, stroke, neurotraumatic injuries and bipolar disorders; 5-acetyl-3-[3-(methoxycarbonylpropylamino)-(benzo-[1.3]dioxyo-5-yl)-methylidene]-2-indolinone for example
09/22/2005US20050209301 Resistance-repellent retroviral protease inhibitors
09/22/2005US20050209282 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209195 Derivatives of compound 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-2H-indol-2-one; Antitumor agents; tyrosine kinase inhibitors
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209164 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
09/22/2005US20050208125 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatmetn of central nervous system disturbances
09/22/2005DE10253426B4 Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
09/22/2005DE102004010893A1 Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New ß-keto amide compounds with MCH-antagonistic effect and pharmaceutical compositions containing them
09/22/2005CA2601038A1 Methods and compositions for treating cancer
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2559328A1 Resistance-repellent retroviral protease inhibitors
09/22/2005CA2559143A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005CA2559139A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005CA2559115A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2557495A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557307A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557247A1 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/21/2005EP1577298A1 Process for determining the purity of amlodipine
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575882A2 Copper catalyzed arylation
09/21/2005EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP0959881B1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
09/21/2005CN1671818A Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions
09/21/2005CN1671692A Method for producing highly pure hydroxy indolyl glyoxylic acid amides
09/21/2005CN1671660A 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671655A Novel phthalamide derivatives
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946565 Process for the preparation of an indole derivative
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946454 Thio-oxindole derivatives
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/20/2005CA2188796C Heterocyclylbenzonitriles
09/20/2005CA2097676C 2,2-dimethyl 3[(z)1-propenyl] cyclopropane carboxylic acid and intermediates, and process for its preparation
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085242A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005WO2005085236A2 Caspase inhibitors and uses thereof
09/15/2005WO2005085221A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/15/2005WO2005085197A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005WO2005085196A2 Inhibitors of dna methylation in tumor cells
09/15/2005WO2005085195A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005084664A1 Indole derivatives and uses thereof
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2004101516A3 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005WO2004060313A3 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
09/15/2005US20050203301 Processes for producing 7-isoindoline-quinolone carboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient
09/15/2005US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents
09/15/2005US20050203165 Perfectly reproducible crystalline form that especially exhibits valuable characteristics for formulation of inhibitors of angiotensin I converting enzyme; preparation from a solution of the salt in CH2Cl2 or ethyl acetate; treating cardiovascular disease
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203112 Bicyclic amides
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments
09/15/2005US20050203103 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
09/15/2005US20050203090 Methods of using N-alkyl-hydroxamic acid-isoindolyl compounds
09/15/2005CA2557758A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005CA2557645A1 Caspase inhibitors and uses thereof
09/15/2005CA2557581A1 Inhibitors of dna methylation in tumor cells
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2557301A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005CA2552907A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/14/2005EP1574508A1 Process for the preparation of acetals and ketals of 3-amimo-5-(hydroxymethyl)-cyclopentane-1,2-diols and their derivatives and salts
09/14/2005EP1574499A1 Inhibitors of DNA methylation in tumor cells
09/14/2005EP1572696A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
09/14/2005EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
09/14/2005EP1572647A2 Synthesis of amines and intermediates for the synthesis thereof
09/14/2005EP1572646A1 N-(indolethyl-)cacloamine compounds
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 458